Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday

Harvard Bioscience (NASDAQ:HBIO) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect Harvard Bioscience to post earnings of $0.07 per share and revenue of $24.15 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Harvard Bioscience Stock Down 5.5 %

HBIO stock opened at $0.77 on Tuesday. Harvard Bioscience has a fifty-two week low of $0.77 and a fifty-two week high of $4.70. The business’s 50 day moving average price is $1.54 and its two-hundred day moving average price is $2.13. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.91 and a current ratio of 2.06. The company has a market capitalization of $33.76 million, a price-to-earnings ratio of -2.35 and a beta of 1.46.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Harvard Bioscience stock. Bank of America Corp DE increased its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 44.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 38,883 shares of the medical instruments supplier’s stock after buying an additional 11,948 shares during the period. Bank of America Corp DE owned 0.09% of Harvard Bioscience worth $82,000 as of its most recent filing with the Securities & Exchange Commission. 80.87% of the stock is currently owned by institutional investors and hedge funds.

About Harvard Bioscience

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.